My portion sizes have gotten smaller (gone are the days of multiple value meals for one person)
10.1111/dom.14089 10 BornerT.TinsleyI
Food and Drug Administration (FDA) has approved semaglutide (marketed as Wegovy) and Tirzepatide (marketed as Zepbound) specifically for chronic weight management in adults with obesity or overweight individuals with at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol
It often means your body is reacting to a new signal
Like other GLP-1 drugs, Foundayo can cause side effects such as nausea, constipation, diarrhea, vomiting, abdominal pain, and headache, according to the FDA
patients present a clinical picture similar to the induced by drugs, that is triggered within the following 24 to 48 hours after the ingestion of faba beans